983 filings
Page 7 of 50
8-K
41mmskkruuy a3eg
25 Oct 21
Seelos Therapeutics Presents a Poster on SLS-002 (Intranasal Racemic Ketamine) at the 2021 IASR/AFSP International Summit on Suicide Research
2:03pm
4
9kdpj
2 Sep 21
SEELOS THERAPEUTICS / MARGARET DALESANDRO ownership change
4:08pm
3
rsueywt
2 Sep 21
SEELOS THERAPEUTICS / MARGARET DALESANDRO ownership change
4:07pm
3
5sy82j
2 Sep 21
SEELOS THERAPEUTICS / Michael Joseph Golembiewski ownership change
4:03pm
8-K
zlywvuvy p8tnsgt
2 Sep 21
Seelos Therapeutics Announces Senior Management Appointments
4:01pm
8-K
4porhl59t 3w3y5
17 Jun 21
Termination of a Material Definitive Agreement
4:14pm
8-K
8bze dusf5hb6nfd1yc
24 May 21
Seelos Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
4:15pm
8-K
5tz15c
21 May 21
Material Modifications to Rights of Security Holders
4:29pm
8-K
m11t7xtrdjxzx
21 May 21
Seelos Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
12:00am
424B5
3ycvppqgvktsjc6
21 May 21
Prospectus supplement for primary offering
12:00am
424B5
o8c0eyv1 g36
19 May 21
Prospectus supplement for primary offering
4:08pm
8-K
6am47n1zfklur2rt
17 May 21
Regulation FD Disclosure
6:12am
S-8
6ad 8mgxx
30 Apr 21
Registration of securities for employees
12:00am
DEFA14A
4jtrwa8zrfb7aa
26 Apr 21
Additional proxy soliciting materials
5:15pm
4
iexxxm3l
17 Mar 21
SEELOS THERAPEUTICS / Raj Mehra ownership change
4:41pm